Citadel Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,040
Closed -$4.76K 6859
2023
Q2
$4.76K Sell
25,040
-35,266
-58% -$6.7K ﹤0.01% 5465
2023
Q1
$20.5K Sell
60,306
-23,858
-28% -$8.11K ﹤0.01% 5388
2022
Q4
$25K Buy
+84,164
New +$25K ﹤0.01% 5500
2022
Q2
Sell
-12,240
Closed -$15K 7274
2022
Q1
$15K Buy
+12,240
New +$15K ﹤0.01% 6178
2021
Q4
Hold
0
7482
2021
Q3
Hold
0
7349
2021
Q2
Hold
0
7334
2021
Q1
Hold
0
6972
2020
Q3
Sell
-17,691
Closed -$63K 5462
2020
Q2
$63K Buy
+17,691
New +$63K ﹤0.01% 4322
2020
Q1
Sell
-28,706
Closed -$63K 5462
2019
Q4
$63K Buy
28,706
+15,743
+121% +$34.6K ﹤0.01% 4355
2019
Q3
$24K Buy
+12,963
New +$24K ﹤0.01% 4481
2019
Q2
Sell
-23,544
Closed -$46K 5237
2019
Q1
$46K Buy
23,544
+4,386
+23% +$8.57K ﹤0.01% 4256
2018
Q4
$25K Sell
19,158
-16,308
-46% -$21.3K ﹤0.01% 4220
2018
Q3
$87K Sell
35,466
-18,259
-34% -$44.8K ﹤0.01% 3929
2018
Q2
$181K Buy
53,725
+43,604
+431% +$147K ﹤0.01% 3719
2018
Q1
$43K Buy
+10,121
New +$43K ﹤0.01% 3770
2017
Q4
Sell
-10,646
Closed -$41K 4390
2017
Q3
$41K Buy
+10,646
New +$41K ﹤0.01% 3430
2017
Q2
Sell
-34,163
Closed -$124K 4316
2017
Q1
$124K Buy
+34,163
New +$124K ﹤0.01% 3294
2016
Q4
Sell
-32,661
Closed -$106K 4244
2016
Q3
$106K Buy
+32,661
New +$106K ﹤0.01% 3191
2016
Q2
Hold
0
4041
2015
Q3
Sell
-23,076
Closed -$31K 4375
2015
Q2
$31K Sell
23,076
-8,999
-28% -$12.1K ﹤0.01% 3513
2015
Q1
$27K Sell
32,075
-4,307
-12% -$3.63K ﹤0.01% 3486
2014
Q4
$15K Buy
36,382
+31,893
+710% +$13.1K ﹤0.01% 3711
2014
Q3
$20K Buy
+4,489
New +$20K ﹤0.01% 3307
2014
Q2
Sell
-39,506
Closed -$216K 3815
2014
Q1
$216K Buy
+39,506
New +$216K ﹤0.01% 2804